BR9608633A - Utilização de derivados de pirrolidina e do ácido (tercbutóxicarbonil-4 (fluoro-2 fenil)-2 fenil)2 tiazolidinil-3(2R.4R)-2 oxo-2etil)-3 ureído)-3 fenil)-2 propiónico no tratamento do alcoolismo - Google Patents

Utilização de derivados de pirrolidina e do ácido (tercbutóxicarbonil-4 (fluoro-2 fenil)-2 fenil)2 tiazolidinil-3(2R.4R)-2 oxo-2etil)-3 ureído)-3 fenil)-2 propiónico no tratamento do alcoolismo

Info

Publication number
BR9608633A
BR9608633A BR9608633A BR9608633A BR9608633A BR 9608633 A BR9608633 A BR 9608633A BR 9608633 A BR9608633 A BR 9608633A BR 9608633 A BR9608633 A BR 9608633A BR 9608633 A BR9608633 A BR 9608633A
Authority
BR
Brazil
Prior art keywords
phenyl
2ethyl
thiazolidinyl
ureido
butoxycarbonyl
Prior art date
Application number
BR9608633A
Other languages
English (en)
Inventor
Assunta Imperato
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of BR9608633A publication Critical patent/BR9608633A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
BR9608633A 1995-06-01 1996-05-29 Utilização de derivados de pirrolidina e do ácido (tercbutóxicarbonil-4 (fluoro-2 fenil)-2 fenil)2 tiazolidinil-3(2R.4R)-2 oxo-2etil)-3 ureído)-3 fenil)-2 propiónico no tratamento do alcoolismo BR9608633A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9506530A FR2734724B1 (fr) 1995-06-01 1995-06-01 Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'alcoolisme
PCT/FR1996/000801 WO1996038139A1 (fr) 1995-06-01 1996-05-29 Utilisation de derives de pyrrolidine au traitement de l'alcoolisme

Publications (1)

Publication Number Publication Date
BR9608633A true BR9608633A (pt) 1999-02-02

Family

ID=9479586

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608633A BR9608633A (pt) 1995-06-01 1996-05-29 Utilização de derivados de pirrolidina e do ácido (tercbutóxicarbonil-4 (fluoro-2 fenil)-2 fenil)2 tiazolidinil-3(2R.4R)-2 oxo-2etil)-3 ureído)-3 fenil)-2 propiónico no tratamento do alcoolismo

Country Status (27)

Country Link
US (1) US5935980A (pt)
EP (1) EP0828486B1 (pt)
JP (1) JPH11511747A (pt)
KR (1) KR100424997B1 (pt)
CN (1) CN1186432A (pt)
AT (1) ATE224190T1 (pt)
AU (1) AU711625B2 (pt)
BG (1) BG63189B1 (pt)
BR (1) BR9608633A (pt)
CA (1) CA2219455C (pt)
CZ (1) CZ289344B6 (pt)
DE (1) DE69623767T2 (pt)
DK (1) DK0828486T3 (pt)
EA (1) EA000722B1 (pt)
ES (1) ES2182987T3 (pt)
FR (1) FR2734724B1 (pt)
GE (1) GEP19991780B (pt)
HU (1) HUP9900748A3 (pt)
IL (1) IL118491A (pt)
NO (1) NO975488L (pt)
NZ (1) NZ310488A (pt)
PT (1) PT828486E (pt)
RO (1) RO117297B1 (pt)
SK (1) SK282063B6 (pt)
UA (1) UA58492C2 (pt)
WO (1) WO1996038139A1 (pt)
ZA (1) ZA964270B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744361B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
FR2744363B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application de derives de thiazolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
FR2744362B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
TW442449B (en) 1996-07-04 2001-06-23 Hoechst Ag Process for preparing 1,2-dichloroethane by direct chlorination
WO2002072582A1 (en) 2001-03-12 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Methods for the synthesis of densely functionalized pyrrolidine template libraries
US6869335B2 (en) 2002-07-08 2005-03-22 Micron Technology, Inc. Retaining rings, planarizing apparatuses including retaining rings, and methods for planarizing micro-device workpieces
US8247438B2 (en) 2008-02-27 2012-08-21 Neuropill, Inc. Methods for treating schizophrenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678938B1 (fr) * 1991-07-10 1993-10-08 Rhone Poulenc Rorer Sa Derives de pyrrolidine, leur preparation et les medicaments les contenant.
GB9203790D0 (en) * 1992-02-21 1992-04-08 Merck Sharp & Dohme Therapeutic agents
FR2700166B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.

Also Published As

Publication number Publication date
ATE224190T1 (de) 2002-10-15
BG102087A (en) 1998-10-30
DK0828486T3 (da) 2003-01-27
EP0828486B1 (fr) 2002-09-18
IL118491A0 (en) 1996-09-12
ZA964270B (en) 1996-08-26
EA000722B1 (ru) 2000-02-28
MX9708875A (es) 1998-03-31
AU6129096A (en) 1996-12-18
CZ378597A3 (cs) 1998-03-18
CA2219455C (fr) 2009-02-24
BG63189B1 (bg) 2001-06-29
ES2182987T3 (es) 2003-03-16
SK282063B6 (sk) 2001-10-08
IL118491A (en) 2002-05-23
EP0828486A1 (fr) 1998-03-18
GEP19991780B (en) 1999-10-05
US5935980A (en) 1999-08-10
FR2734724A1 (fr) 1996-12-06
PT828486E (pt) 2002-12-31
CZ289344B6 (cs) 2002-01-16
KR100424997B1 (ko) 2004-06-23
HUP9900748A3 (en) 2000-01-28
EA199700439A1 (ru) 1998-08-27
DE69623767T2 (de) 2003-07-03
UA58492C2 (uk) 2003-08-15
CA2219455A1 (fr) 1996-12-05
NO975488D0 (no) 1997-11-28
FR2734724B1 (fr) 1997-07-04
NO975488L (no) 1998-01-19
KR19990021859A (ko) 1999-03-25
WO1996038139A1 (fr) 1996-12-05
DE69623767D1 (de) 2002-10-24
NZ310488A (en) 2000-07-28
AU711625B2 (en) 1999-10-21
JPH11511747A (ja) 1999-10-12
HUP9900748A1 (hu) 1999-07-28
CN1186432A (zh) 1998-07-01
RO117297B1 (ro) 2002-01-30
SK161197A3 (en) 1998-05-06

Similar Documents

Publication Publication Date Title
DE69626660T2 (de) 2-alkylpyrrolidine
DK0867184T3 (da) Anvendelse af tiagabin til behandling af søvnforstyrrelser
ATE163259T1 (de) Mittel zur regulierung vom hautfettigkeitsgrad
BR9608591A (pt) Compostos de imidazol
DE69512930T2 (de) Stilben-derivate verwendbar als cyclooxygenase-2 hemmer
BR9912501A (pt) Tratamento de distúrbios hiperproliferativos
ATE316976T1 (de) O-aryl glucosid sglt2 inhibitoren und verfahren
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
DE69534908D1 (de) Verwendung von statin zur behandlung von hauterkrankungen
BR9608633A (pt) Utilização de derivados de pirrolidina e do ácido (tercbutóxicarbonil-4 (fluoro-2 fenil)-2 fenil)2 tiazolidinil-3(2R.4R)-2 oxo-2etil)-3 ureído)-3 fenil)-2 propiónico no tratamento do alcoolismo
BG102064A (en) Method for increasing the retinal blood circulation
FI953002A0 (fi) Menetelmä kroonisen eturauhastulehduksen hoitamiseksi 17beta-N-monosubstituoiduilla karbamoyyli-4-atsa-5alfa-androst-1-en-3-oneilla
DE59900067D1 (de) Verwendung eines Mittels zur Haarbehandlung
GB9607119D0 (en) Compounds
EP1645272A3 (en) Daidzin derivatives for the treatment of alcohol dependence or alcohol abuse
SE9403861D0 (sv) Novel medicinal use
ATE160782T1 (de) Fluoro-nukleosid-reinigung

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25D Requested change of name of applicant approved

Owner name: AVENTIS PHARMA S.A. (FR)

Free format text: ALTERADO DE: RHONE-POULENC RORER S.A.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]